DrugPatentWatch Database Preview
Ampicillin sodium - Generic Drug Details
What are the generic drug sources for ampicillin sodium and what is the scope of patent protection?
Ampicillin sodium
is the generic ingredient in seven branded drugs marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Aurobindo Pharma, Consolidated Pharm, Hanford Gc, Hospira Inc, Intl Medication, Istituto Bio Ita Spa, Lilly, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Watson Labs Inc, West-ward Pharms Int, Wyeth Ayerst, Bristol, Glaxosmithkline, Acs Dobfar, Astral, Pharm Assoc, and Pfizer, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.There are seventy drug master file entries for ampicillin sodium. Fifteen suppliers are listed for this compound.
Summary for ampicillin sodium
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 22 |
| NDAs: | 56 |
| Drug Master File Entries: | 70 |
| Suppliers / Packagers: | 15 |
| Bulk Api Vendors: | 48 |
| Clinical Trials: | 8 |
| Patent Applications: | 1,319 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ampicillin sodium at DailyMed |
Recent Clinical Trials for ampicillin sodium
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| DongGuk University | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for ampicillin sodium
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for ampicillin sodium
US Patents and Regulatory Information for ampicillin sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065310-002 | Jul 25, 2006 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hospira Inc | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 090375-002 | Dec 21, 2011 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sandoz | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 061395-004 | Approved Prior to Jan 1, 1982 | AP | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Antibiotice | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090354-003 | Dec 28, 2009 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lilly | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062565-003 | Jun 24, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sandoz | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 061395-002 | Approved Prior to Jan 1, 1982 | AP | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Glaxosmithkline | TOTACILLIN-N | ampicillin sodium | INJECTABLE;INJECTION | 060677-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
